Document:

Exhibit 4.2

 

FIRST SUPPLEMENTAL INDENTURE

 

dated as of December 12, 2011

 

among

 

PHH CORPORATION
 as Issuer

 

and

 

THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A.
 as Trustee
 to the Indenture dated as of August 11, 2010

 

 

9 1⁄4% Senior Notes due 2016

 

 

TABLE OF CONTENTS

 

 

	
 
    	
PAGE
    
	
 
    	
 
    
	
ARTICLE 1
    	
 
    
	
RELATION TO INDENTURE; DEFINITIONS
    	
 
    
	
 
    	
 
    
	
Section 1.01. Relation to Indenture
    	
1
    
	
Section 1.02. Definitions
    	
2
    
	
 
    	
 
    
	
ARTICLE 2
    	
 
    
	
ADDITIONAL NOTES
    	
 
    
	
 
    	
 
    
	
Section 2.01.   Issue of Additional Notes
    	
2
    
	
Section 2.02. Form Of Notes, Authentication Certificate
    	
2
    
	
 
    	
 
    
	
ARTICLE 3
    	
 
    
	
MISCELLANEOUS
    	
 
    
	
 
    	
 
    
	
Section 3.01. Certain Trustee Matters
    	
2
    
	
Section 3.02. Continued Effect
    	
2
    
	
Section 3.03. Provisions Binding on Company’s Successors
    	
3
    
	
Section 3.04. Governing Law
    	
3
    
	
Section 3.05. Counterparts
    	
3
    

 

 

FIRST SUPPLEMENTAL INDENTURE, dated as of December 12, 2011 (this “First Supplemental Indenture”), between PHH CORPORATION, a Maryland corporation (the “Company”), and THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., as trustee under the Indenture referred to below (in such capacity, the “Trustee”).

 

RECITALS OF THE COMPANY

 

WHEREAS, the Company and the Trustee entered into an Indenture dated as of August 11, 2010 (the “Indenture”), relating to the Company’s 9 1⁄4% Senior Notes due 2016, and, if and when issued, any Additional Notes, together with any Exchange Notes issued therefor, as provided in the Indenture (the “Notes”);

 

WHEREAS, pursuant to Section 9.01 of the Indenture, the Company and the Trustee, may modify, amend or supplement the Indenture without the consent of any Holder of Notes to provide for the issuance of Additional Notes in accordance with the limitations set forth in the Indenture;

 

WHEREAS, Additional Notes, if issued pursuant to the Indenture, shall (i) have the same terms in all respects as the Original Notes (although they may bear a different CUSIP number), or in all respects except with respect to the date of issuance and issue price, interest paid or payable on or prior to the first Interest Payment Date after the issuance of such Additional Notes and rights under the Registration Rights Agreement dated August 11, 2010, and (ii) vote together for all purposes as a single class with the Notes originally issued pursuant thereto;

 

WHEREAS, the Company has duly authorized the execution and delivery of this First Supplemental Indenture, and all things necessary to make this First Supplemental Indenture a legal, valid and binding agreement of the Company, in accordance with its terms, have been done; and

 

WHEREAS, all things necessary to make the Additional Notes, when executed by the Company and authenticated and delivered by the Trustee and duly issued by the Company, the legal, valid and binding obligations of the Company as provided in the Indenture and this First Supplemental Indenture;

 

NOW, THEREFORE, for and in consideration of the premises and the purchase of the Notes by the Holders thereof, it is mutually covenanted and agreed, for the equal and proportionate benefit of all Holders of the Notes, as follows:

 

ARTICLE 1
  RELATION TO INDENTURE; DEFINITIONS

 

Section 1.01.  Relation to Indenture.  This First Supplemental Indenture constitutes an integral part of the Indenture.

 

1

 

Section 1.02.  Definitions.  For all purposes of this First Supplemental Indenture, capitalized terms used herein and not otherwise defined herein shall have the meanings assigned thereto in the Indenture.

 

ARTICLE 2
  ADDITIONAL NOTES

 

Section 2.01.  Issue of Additional Notes.  Pursuant to Section 9.01 of the Indenture, the Indenture is hereby supplemented to permit the Company to issue Additional Notes in accordance with the limitations set forth in the Indenture.

 

Section 2.02.  Form Of Notes, Authentication Certificate.  The Additional Notes initially shall be issuable in the form of one or more Global Notes, registered in the name of the Depositary or its nominee.  The form and terms of the Additional Notes and the Trustee’s certificate of authentication shall be substantially as set forth in Exhibit A hereto.  Except as otherwise provided herein, the Additional Notes shall in all respects be subject to the terms, conditions and covenants of the Indenture, as supplemented by this First Supplemental Indenture (including the applicable form of Additional Note set forth as Exhibit A hereto (the terms of which are incorporated in and made a part of this First Supplemental Indenture for all intents and purposes)).  In the event of any inconsistency between the provisions of this First Supplemental Indenture and the provisions of the Indenture, the provisions of this First Supplemental Indenture shall be controlling with respect to the Additional Notes.

 

ARTICLE 3
  MISCELLANEOUS

 

Section 3.01.  Certain Trustee Matters.  The Recitals of the Company contained herein shall be taken as the statements of the Company, and the Trustee assumes no responsibility for their correctness.  The Trustee makes no representations as to the validity or sufficiency of this First Supplemental Indenture or the Additional Notes or the proper authorization or the due execution hereof or thereof by the Company.

 

Section 3.02.  Continued Effect.  Except as expressly supplemented and amended by this First Supplemental Indenture, the Indenture shall continue in full force and effect in accordance with the provisions thereof, and the Indenture (as supplemented and amended by this First Supplemental Indenture) is in all respects hereby ratified and confirmed. This First Supplemental Indenture and all the terms and conditions of this First Supplemental Indenture shall be deemed to be part of the terms and conditions of the Indenture for any and all purposes.

 

2

 

Section 3.03. Provisions Binding on Company’s Successors.  All obligations of the Company pursuant to this First Supplemental Indenture shall bind its successors and assigns whether so expressed or not.

 

Section 3.04. Governing Law.  THE FIRST SUPPLEMENTAL INDENTURE AND THE ADDITIONAL NOTES SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK.

 

Section 3.05.  Counterparts.  This instrument may be executed in any number of counterparts, each of which so executed shall be deemed to be an original, but all such counterparts shall together constitute but one and the same instrument.

 

(Signature Pages Follow)

 

3

 

IN WITNESS WHEREOF, the parties hereto have caused this First Supplemental Indenture to be duly executed as of the day and year first above written.

 

	
 
    	
PHH CORPORATION
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
  /s/   Mark E. Johnson
    
	
 
    	
 
    	
Name: Mark E.   Johnson
    
	
 
    	
 
    	
Title: Senior Vice   President and Treasurer
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A.
    
	
 
    	
as Trustee
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
  /s/ Cathy   Flowers
    
	
 
    	
 
    	
Authorized   Signatory
    

 

[Signature Page of First Supplemental Indenture]

 

4

 

Exhibit A

 

[UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (“DTC”), TO THE COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO CEDE & CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE & CO., HAS A BENEFICIAL INTEREST HEREIN.

 

TRANSFERS OF THIS GLOBAL NOTE ARE LIMITED TO TRANSFERS IN WHOLE, BUT NOT IN PART, TO NOMINEES OF CEDE & CO. OR TO A SUCCESSOR THEREOF OR SUCH SUCCESSOR’S NOMINEE AND TRANSFERS OF PORTIONS OF THIS GLOBAL NOTE ARE LIMITED TO TRANSFERS MADE IN ACCORDANCE WITH THE TRANSFER PROVISIONS OF THE INDENTURE.](1)

 

PHH CORPORATION

 

9 1⁄4% Senior Note Due 2016

 

	
 
    	
 
    	
CUSIP
    
	
 
    	
 
    	
 
    
	
No.
    	
 
    	
$
    	
                                           
    

 

PHH Corporation, a Maryland corporation (the “Company”, which term includes any successor under the Indenture hereinafter referred to), for value received, promises to pay to Cede & Co., or its registered assigns, the principal sum of                          DOLLARS ($            ) [or such other amount as indicated on the Schedule of Exchange of Notes attached hereto](2) on March 1, 2016.

 

Interest Rate:                         9 1⁄4% per annum.

 

(1)  Include in global note only

 

(2)  Include in global note only

 

1

 

Interest Payment Dates:  March 1 and September 1, commencing               , 20    .

 

Regular Record Dates:  February 15 and August 15.

 

Reference is hereby made to the further provisions of this Note set forth on the reverse hereof, which will for all purposes have the same effect as if set forth at this place.

 

2

 

IN WITNESS WHEREOF, the Company has caused this Note to be signed manually or by facsimile by its duly authorized officers.

 

	
 
    	
Date:
    	
PHH CORPORATION
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
 
    
	
 
    	
 
    	
Name:
    
	
 
    	
 
    	
Title:
    

 

3

 

(Form of Trustee’s Certificate of Authentication)

 

This is one of the 9 1⁄4% Senior Notes Due 2016 described in the Indenture referred to in this Note.

 

 

	
 
    	
 
    	
The Bank of New   York Mellon Trust Company, N.A., as Trustee
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
By:
    	
 
    
	
 
    	
 
    	
 
    	
Authorized   Signatory
    
	
Date:
    	
 
    	
 
    	
 
    
					

 

4

 

[REVERSE SIDE OF NOTE]

 

PHH CORPORATION

 

9 1⁄4% Senior Note Due 2016

 

1.                                       Principal and Interest.

 

The Company promises to pay the principal of this Note on March 1, 2016.

 

The Company promises to pay interest on the principal amount of this Note on each interest payment date, as set forth on the face of this Note, at the rate of 9.25% per annum.

 

Interest will be payable semiannually (to the holders of record of the Notes at the close of business on the February 15 or August 15 immediately preceding the interest payment date) on each interest payment date, commencing             , 20    .

 

Interest on this Note will accrue from the most recent date to which interest has been paid on this Note (or, if there is no existing default in the payment of interest and if this Note is authenticated between a regular record date and the next interest payment date, from such interest payment date) or, if no interest has been paid, from                   , 20     .  Interest will be computed on the basis of a 360-day year of twelve 30-day months.

 

The Company will pay interest on overdue principal, premium, if any, and, to the extent lawful, interest at the rate applicable to this Note.  Interest not paid when due and any interest on principal, premium or interest not paid when due will be paid to the Persons that are Holders on a special record date, which will be the 15th day preceding the date fixed by the Company for the payment of such interest, whether or not such day is a Business Day.  At least 15 days before a special record date, the Company will send to each Holder and to the Trustee a notice that sets forth the special record date, the payment date and the amount of interest to be paid.

 

2.                                       Indentures.

 

This is one of the Notes issued under an Indenture dated as of August 11, 2010 (as supplemented and amended by the First Supplemental Indenture, dated December 12, 2011, and as further supplemented and amended from time to time, the “Indenture”), between the Company and The Bank of New York Mellon Trust Company, N.A., as Trustee.  Capitalized terms used herein are used as defined in the Indenture unless otherwise indicated.  The terms of the Notes include those stated in the Indenture and those made part of the Indenture by reference to the Trust Indenture Act.  The Notes are subject to all such terms, and Holders are referred to the Indenture and the Trust Indenture Act for a statement

 

5

 

of all such terms.  To the extent permitted by applicable law, in the event of any inconsistency between the terms of this Note and the terms of the Indenture, the terms of the Indenture will control.

 

The Notes are general unsecured obligations of the Company.  The Indenture limits the original aggregate principal amount of the Notes to $350,000,000, but Additional Notes may be issued pursuant to the Indenture, and the originally issued Notes and all such Additional Notes vote together for all purposes as a single class.

 

3.                                       Redemption and Repurchase; Discharge Prior to Redemption or Maturity.

 

This Note is subject to optional redemption, and may be the subject of an Offer to Purchase, as further described in the Indenture.  There is no sinking fund or mandatory redemption applicable to this Note.

 

If the Company deposits with the Trustee money or U.S. Government Obligations sufficient to pay the then outstanding principal of, premium, if any, and accrued interest on the Notes to redemption or maturity, the Company may in certain circumstances be discharged from the Indenture and the Notes or may be discharged from certain of its obligations under certain provisions of the Indenture.

 

4.                                       Registered Form; Denominations; Transfer; Exchange.

 

The Notes are in registered form, without interest coupons, in denominations of $2,000 and higher integral multiples of $1,000.  A Holder may register the transfer or exchange of Notes in accordance with the Indenture.  The Trustee may require a Holder to furnish appropriate endorsements and transfer documents and to pay any taxes and fees required by law or permitted by the Indenture.  Pursuant to the Indenture, there are certain periods during which the Trustee will not be required to issue, register the transfer of or exchange any Note or certain portions of a Note.

 

5.                                       Defaults and Remedies.

 

If an Event of Default with respect to the Notes shall occur and be continuing, the Trustee or the Holders of at least 25% in principal amount of the outstanding Notes may declare the principal and accrued interest of all of the Notes to be due and payable immediately.  If a bankruptcy or insolvency default with respect to the Company occurs and is continuing, the Notes automatically become due and payable.  Holders may not enforce the Indenture or the Notes except as provided in the Indenture.  The Trustee may require indemnity satisfactory to it before it enforces the Indenture or the Notes.  Subject to certain limitations, Holders of a majority in principal amount of the Notes then outstanding may direct the Trustee in its exercise of remedies.

 

6

 

6.                                       Amendment and Waiver.

 

Under the Indenture, the Company’s rights and obligations and the rights of the Holders of the Notes may be changed and compliance with certain covenants or a past default may be waived. Subject to certain exceptions, any change requires the consent of the Holders of a majority in principal amount of the outstanding Notes; provided that no such modification shall, without the consent of the Holder of each Note affected thereby change certain rights of the Holders of the Notes specified in the Indenture.  Without the consent of any Holder, the Company and the Trustee may modify, amend or supplement the Indenture or the Notes to, among other things, cure any ambiguity, defect, mistake or inconsistency in the Indenture.

 

7.                                       Authentication.

 

This Note is not valid until the Trustee (or Authenticating Agent) signs the certificate of authentication on the other side of this Note.

 

8.                                       Governing Law.

 

This Note shall be governed by, and construed in accordance with, the laws of the State of New York.

 

9.                                       Abbreviations.

 

Customary abbreviations may be used in the name of a Holder or an assignee, such as:  TEN COM (= tenants in common), TEN ENT (= tenants by the entireties), JT TEN (= joint tenants with right of survivorship and not as tenants in common), CUST (= Custodian) and U/G/M/A/ (= Uniform Gifts to Minors Act).

 

The Company will furnish a copy of the Indenture to any Holder upon written request and without charge.

 

7

 

[FORM OF TRANSFER NOTICE]

 

FOR VALUE RECEIVED the undersigned registered holder hereby sell(s), assign(s) and transfer(s) unto

 

	
Insert Taxpayer   Identification No.
    
	
 
    
	
 
    
	
 
    
	
Please   print or typewrite name and address including zip code of assignee
    
	
 
    
	
 
    
	
the within   Note and all rights thereunder, hereby irrevocably constituting and   appointing
    
	
 
    
	
 
    

 

attorney to transfer said Note on the books of the Company with full power of substitution in the premises.

 

	
Signature Guarantee:(3)
    	
 
    	
 
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By
    	
 
    	
 
    
	
 
    	
To be executed by   an executive officer
    
				

 

(3)  Signatures must be guaranteed by an “eligible guarantor institution” meeting the requirements of the Registrar, which requirements include membership or participation in the Securities Transfer Association Medallion Program (“STAMP”) or such other “signature guarantee program” as may be determined by the Registrar in addition to, or in substitution for, STAMP, all in accordance with the Securities Exchange Act of 1934, as amended.

 

8

 

OPTION OF HOLDER TO ELECT PURCHASE

 

If you wish to have all of this Note purchased by the Company pursuant to Section 3.03 of the Indenture, check the box: 9

 

If you wish to have a portion of this Note purchased by the Company pursuant to Section 3.03 of the Indenture, state the amount (in original principal amount) below:

 

$                                          .

 

 

	
Date:
    	
 
    	
 
    
	
 
    	
 
    
	
Your   Signature:
    	
 
    	
 
    
	
 
    	
 
    
	
(Sign   exactly as your name appears on the other side of this Note)
    	
 
    
	
 
    	
 
    
	
Signature   Guarantee:(4)
    	
 
    	
 
    
							

 

(4)  Signatures must be guaranteed by an “eligible guarantor institution” meeting the requirements of the Trustee, which requirements include membership or participation in the Securities Transfer Association Medallion Program (“STAMP”) or such other “signature guarantee program” as may be determined by the Trustee in addition to, or in substitution for, STAMP, all in accordance with the Securities Exchange Act of 1934, as amended.

 

9

 

[SCHEDULE OF EXCHANGES OF NOTES](5)

 

The following exchanges of a part of this Global Note for Physical Notes or a part of another Global Note have been made:

 

	
Date of Exchange
    	
 
    	
Amount of decrease
   in principal amount
   of this Global Note
    	
 
    	
Amount of increase
   in principal amount
   of this Global Note
    	
 
    	
Principal amount of
   this Global Note
   following such
   decrease (or
   increase)
    	
 
    	
Signature of
   authorized officer of
   Trustee
    	
 
    
	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    

 

(5)  Include in global note only

 

10Exhibit 10.1

 

December 6, 2011

 

Mr. Derik Mooberry

4880 Warren Way

Reno, NV 89509

 

RE:          Employment Offer

 

Dear Derik:

 

Bally Technologies (the “Company”) is pleased to offer you continued employment with the Company under the following terms and conditions.  The effective date of this offer letter will be December 6, 2011 (the “Effective Date”).  Notwithstanding anything herein to the contrary, either you or the Company may terminate your employment at any time with or without cause, with the rights and obligations of the parties upon termination of your employment limited strictly to the terms of this letter agreement.

 

Further, the terms and conditions of this letter agreement shall be conditional upon the continuous review and approval of Bally Technologies’ Compliance Committee.

 

1.             Definitions.

 

“Cause” means the following events leading to termination of employment as determined by the Company, upon reasonable investigation, in its judgment and discretion, as the case may be after: (1) a substantial act or omission which is dishonest or fraudulent against the Company, (2) a conviction of a felony or conviction of a gross misdemeanor involving moral turpitude or criminal conduct against any person or property, including without limitation, the Company, (3) a substantial act or omission that constitutes willful misconduct in the performance of your job responsibilities or failure to adhere to the Company’s then-current policies, procedures or rules (4) any improper or illegal act, omission or pattern of conduct in the performance of your job responsibilities, which is not remedied by you within thirty (30) days of your receipt of written notice from the Company, (5)  any material breach of this letter agreement by you, or (6) failure to comply with any provision of the gaming laws of the State of Nevada or the rules and regulations of the Nevada Gaming Control Board or the Nevada Gaming Commission or any gaming law, ordinance, rule or regulation of any city or county having jurisdiction, or the gaming laws, regulations and rules of any other nation, state, county or other jurisdiction in which the Company may be doing business at any time which will materially and negatively affect the registration and licensing of the Company.

 

 

“Salary Continuation” means the Company’s continued payment of your then-current base salary on normal paydays following termination of your employment with the Company, paid under such circumstances described in further detail in this letter agreement, less standard withholding and offset by all income earned from other employment during any period of time that you receive any Salary Continuation.

 

2.             Compensation.

 

A.            Position and Title.  You are hereby offered the position of Senior Vice President, Products and Operations.  You will report to the Chief Operating Officer of Bally Technologies, Inc., or his equivalent as the Company may direct from time to time.  Your duties will generally include oversight and management of the Company’s product development, product marketing, and other activities that the Company may deem appropriate for this position from time to time, along with any other related duties that the Chief Operating Officer may assign to you.

 

B.            Salary.  Your base salary will be $231,750 per year.  Your base salary will be reviewed annually and adjustments may be made at the Company’s option, and based on merit, and all at the Company’s sole discretion.  The Company makes no express representations as to the certainty of any salary increases.

 

C.            Management Incentive Program. Notwithstanding the Effective Date of this letter agreement, and provided that you are then employed by the Company, you will be entitled to participate in the Company’s Senior Management Incentive Program or any successor plan (the “MIP”).  Details of the plan are provided each year under separate cover. .

 

D.            Variable Compensation.  Notwithstanding the Effective Date of this letter agreement, Employee will continue to participate in the established Revenue and Operating Income base incentive programs that are currently in place.  These programs will continue to be modified annually by mutual agreement between the Company and the Employee.

 

E.             Equity Awards.  Subject to the approval of the Board, you will be granted an option on the Effective Date to acquire 4,000 shares of Bally Technologies, Inc. common stock (the “Common Stock”) at the per-share exercise price which will be equal to the market price of a share of Common Stock as of the close of business on the Effective Date, referred to as the “Option.”  In addition, subject to Board approval, on the Effective Date, you will be awarded 4,000 shares of restricted Common Stock, referred to as the “Restricted Stock.”  Subject to the express provisions of this letter agreement, the Option and the Restricted Stock will be issued pursuant to the Bally Technologies, Inc. 2010 Long Term Incentive Plan (the “LTIP”) and the forms of award agreement currently used thereunder, and in accordance with the Company’s then current policies and procedures for equity-based compensation awards.

 

The Option and the Restricted Stock shall vest and, to the extent applicable, be exercisable, at 25% on each of the four anniversaries of the Effective Date, subject to your continued employment with the Company through each vesting date.

 

2

 

F.             Salary Continuation.  If the Company terminates your employment without Cause after the Effective Date, the Company will pay you Salary Continuation for a period of one year immediately following such termination of your employment, subject to: (1) the release agreement described in paragraph F below becoming effective and irrevocable in accordance with its terms; and (2) your continued compliance with the covenants described in Section 3 below.  You will not receive Salary Continuation for any period of time following your termination if the Company terminates your employment for Cause or if you terminate your employment for any reason at any time.

 

G.            Termination Release.  The payment to you of any amounts of cash and equity compensation following termination of your employment with the Company in accordance with Section 2 of this letter agreement shall be conditioned upon the execution by you within 21 days following your termination of employment of a release agreement providing for the release of all claims against the Company or any successor, and the irrevocability of the same.

 

3.             Employment Covenants.

 

A.            Covenant not to compete. You agree not to compete with the Company for as long as you are employed by the Company. You agree not to compete with the Company for one year after your employment with the Company terminates if the Company terminates you for Cause, or if you quit for any reason (the “Non-Compete Period”), on the terms and conditions set forth in Section 2 above.

 

If you are terminated without Cause, you agree not to compete with the Company for one year after your employment with the Company terminates, subject to the terms and conditions set forth in Section 2 above.

 

To “compete” means to establish, engage, or be connected with, directly or indirectly, any person or entity engaged in a business in competition with the business of the Company (which, as defined above, includes any of the Company’s subsidiaries or affiliates) in any area where the Company does business, whether as an employee, owner, partner, agent, employee, officer, consultant, advisor, stockholder (except as the beneficial owner of not more than 5 percent of the outstanding shares of a corporation, any of the capital stock of which is listed on any national or regional securities exchange or quoted in the daily listing of over-the-counter market securities and, in each case, in which you do not undertake any management or operational or advisory role) or in any other capacity, for your own account or for the benefit of any person or entity.

 

You acknowledge and agree that the scope and duration of this covenant not to compete are reasonable and fair. However, if a court of competent jurisdiction determines that this covenant is overly broad or unenforceable in any respect, you and the Company agree that the covenant shall be enforced to the greatest extent the court deems appropriate and that the court may modify this covenant to that extent.

 

B.            Covenant not to solicit customers, employees, or consultants. You agree that during your employment with the Company and for one year after your employment ends for any reason, you shall not, directly or indirectly, (i) aid or endeavor to solicit or induce any other employee or consultant of the Company to leave the Company to accept employment of any kind

 

3

 

with any other person or entity, or (ii) solicit the trade or patronage of any of the Company’s customers (which includes customers of any of the Company’s subsidiaries or affiliates) or of anyone who has traded or dealt with the Company with respect to any technologies, services, products, trade secrets, or other matters in which the Company is active.

 

C.            Confidential information. You agree that your work for the Company will give you access to confidential matters of the Company not publicly known such as proprietary matters of a technical nature (including but not limited to know-how, technical data, gaming processes, gaming equipment, techniques, developments) and proprietary matters of a business nature (including but not limited to information about costs, profits, markets, sales, lists of customers, and matters received by the Company in confidence from other parties), collectively referred to as “Confidential Matters.” Some Confidential Matters may be entitled to protection as “Trade Secrets,” as that term is defined in N.R.S. 600A.030(5), the Restatement of Torts, and case law interpreting the same.

 

You agree to keep secret all such Confidential Matters and agree not to directly or indirectly, other than is necessary in the business of the Company and the scope of your employment, disclose or use any such Confidential Matters at any time except (i) with prior written consent of the Company, (ii) as necessary in any judicial or arbitration action to enforce the provisions of this letter agreement, (iii) in connection with any judicial or administrative proceeding to the extent required by law, and (iv) as otherwise required by law. You agree that all written materials (including correspondence, memoranda, manuals, notes, and notebooks) and all models, mechanisms, devices, drawings, and plans in your possession from time to time (whether or not written or prepared by you) embodying Confidential Matters shall be and remain the sole property of the Company, and you will use all reasonable precautions to assure that all such written materials and models, mechanisms, devices, drawings, and plans are properly protected and kept from unauthorized persons. You further agree to deliver all Confidential Matters, including copies, immediately to the Company on termination of your employment for any reason, or at any time the Company may request.

 

After termination of your employment with the Company for any reason, you shall not reveal directly or indirectly to any person or entity or use for your personal benefit (including without limitation, for the purpose of soliciting business, whether or not competitive with any business of the Company) any Confidential Matters. To the extent that any Confidential Matters are considered by the Company as Trade Secrets, you agree that all limitations on use of these Trade Secrets shall last forever. You further agree that immediately upon or after termination, you will deliver to the Company all memoranda, notes, reports, lists, models, mechanisms, devices, drawings or plans and other documents (and all copies thereof) in your possession relating to the business of the Company or its subsidiaries and affiliates.

 

D.            Intellectual Property. You shall promptly disclose in writing to the Company all inventions, discoveries, concepts, ideas, developments, improvements, and innovations, whether or not patentable, and the expressions of all inventions, discoveries, concepts, ideas, developments, improvements, and innovations, whether or not copyrightable (collectively “Inventions”), conceived, developed, or first actually reduced to practice by you, either alone or with others, during your employment with the Company or during the first six months after your employment with the Company ends for any reason, that (i) relate in any manner to the existing

 

4

 

or contemplated business or research activities of the Company, (ii) are suggested by or result from your work for the Company; or (iii) result from the use of time, materials, or facilities of the Company. All Inventions you conceive, develop, or first actually reduce to practice, either alone or with others, while employed by the Company that relate in any manner to the existing or contemplated business or research activities of the Company shall be the exclusive property of the Company. You assign to the Company your entire right, title, and interest in and to all such Inventions and to all unpatented Inventions that you now own, except those specifically described in a statement that has been separately executed by you and an officer of the Company and attached hereto, provided, however, that if no such list is attached, you represent and warrant that there are no such Inventions. You will, at the request and expense of the Company, execute specific assignments to any such Inventions and execute, acknowledge, and deliver patent applications and such other documents (including but not limited to all provisionals, continuations, continuations-in-part, continued prosecution applications, extensions, re-issues, re-examinations, divisionals and foreign counterparts) and take such further action as may be considered necessary by the Company at any time, whether during your employment with the Company or after it terminates for any reason, to obtain and define letters patent in any and all countries and to vest title to such Inventions and related patents or patent applications in the Company or its assignees. Any Invention that you disclose to a third person or describe in a patent application filed by you or in your behalf during your employment with the Company or within six months after your employment with the Company terminates for any reason shall be presumed to have been conceived or made by you during your employment with the Company unless proved to have been conceived and made by you after the expiration or termination of this letter agreement.

 

You acknowledge that the remuneration you receive in connection with your employment with the Company includes reasonable compensation for the fact that the Intellectual Property rights will vest in the Company and/or its affiliated companies (if so designated by the Company) by operation of law or for the assignment and transfer to the Company of such rights pursuant to this Section 3.

 

E.             Non-disparagement. You and the Company each agree that, during your employment with the Company and after your employment with the Company terminates for any reason, neither shall, publicly or privately, disparage or make any statements (written or oral) that could impugn the integrity, acumen (business or otherwise), ethics, or business practices of the other (including, in the case of the Company, its affiliates and subsidiaries), except, in each case, to the extent (but solely to the extent) necessary (i) in any judicial or arbitration action to enforce the provisions of this letter agreement, or (ii) in connection with any judicial or administrative proceeding to the extent required by applicable law, or (iii) as otherwise required by law.

 

F.             Injunctive relief; jurisdiction. You acknowledge that the Company will suffer irreparable injury, not readily susceptible of valuation in monetary damages, if you breach any of your obligations under this letter agreement. Accordingly, you agree that the Company will be entitled, at its option, to injunctive relief against any breach or prospective breach by you of your obligations under this section in any federal or state court of competent jurisdiction sitting in Nevada, in addition to monetary damages and any other remedies available at law or in equity. You hereby submit to the jurisdiction of such courts for the purposes of any actions or proceedings instituted by the Company to obtain such injunctive relief, and agree that process

 

5

 

may be served on you by registered mail, addressed to your last address known to the Company, or in any other manner authorized by law.  The Company may also suspend any salary continuation payments during any period that you are in breach of this letter agreement and the applicable restricted period shall be extended by any period that you are in breach.

 

G.            Material inducements. The restrictive covenants and other provisions in this letter agreement are material inducements to the Company entering into and performing its obligations under this letter agreement. Accordingly, in the event of any breach of the provisions of this section by you, in addition to all other remedies at law or in equity possessed by the Company, including but not limited to the right to enforce the covenants you have agreed to in this letter agreement, the Company shall have the right to terminate this letter agreement and your employment with the Company and not pay any amounts payable to you under this letter agreement.  In the event any of the provisions of this letter agreement are individually deemed unlawful, any remaining provisions of this letter shall remain in full force and effect.

 

4.             Miscellaneous.

 

The intent of the parties is that payments and benefits under this letter agreement comply with Section 409A of the Internal Revenue Code of 1986, as amended, and the regulations and guidance promulgated thereunder (collectively “Section 409A”) and, accordingly, to the maximum extent permitted, this letter agreement shall be interpreted to be in compliance therewith.  For purposes of this letter agreement, a termination of employment shall not be deemed to have occurred for purposes of any provision of this letter agreement providing for the payment of any amounts or benefits that are considered to be deferred compensation under Section 409A upon or following a termination of employment unless such termination is also a “separation from service” within the meaning of Section 409A.  In addition, if you are deemed on the date of your termination of employment to be a “specified employee” within the meaning of that term under Section 409A(a)(2)(B) of the Internal Revenue Code of 1986, as amended, then with regard to any payment or the provision of any benefit that is considered deferred compensation under Section 409A payable on account of a “separation from service,” and that is not exempt from Section 409A as involuntary separation pay or a short-term deferral (or otherwise), such payment or benefit shall be made or provided at the date which is the earlier of (i) the expiration of the six-month period measured from the date of such “separation from service,” and (ii) the date of your death (the “Delay Period”).  Upon the expiration of the Delay Period, all payments and benefits delayed pursuant to this paragraph (whether they would have otherwise been payable in a single sum or in installments in the absence of such delay) shall be paid or reimbursed to you in a lump sum without interest, and any remaining payments and benefits due under this letter agreement will be paid or provided in accordance with the normal payment dates specified for them herein.  Each payment hereunder shall be deemed a separate payment for purposes of Section 409A.

 

Except as modified by this letter, the terms and conditions of your employment with the Company shall continue to be subject to the Company’s regular employment policies and practices and benefits as may be in effect from time to time.  This letter comprises the entire agreement between you and the Company and supersedes all other oral and written agreements previously entered into by you and the Company concerning the same subject matter.  If accepted, this offer will not create an agreement of employment for any specific term or

 

6

 

otherwise alter the at-will nature of your employment relationship with the Company.  If you accept this offer, either you or the Company may terminate your employment at any time with or without cause.

 

If you accept this offer of employment, please sign below and return this letter to me. Once signed and returned, this letter will comprise a binding agreement between you and the Company.  If you have any questions about its meaning, you are urged to consult with your attorney.

 

Sincerely,

 

	
BALLY   TECHNOLOGIES, INC.
    	
 
    
	
 
    	
 
    
	
 
    	
 
    
	
/s/Gary   Kapral
    	
 
    
	
By:   Gary Kapral
    	
 
    
	
Senior   Vice President, Human Resources
    	
 
    
	
 
    
	
 
    
	
ACCEPTANCE
    
	
 
    
	
I   have read the foregoing letter, and I have reviewed it with counsel or have   had the opportunity to do so. I understand and accept its terms.
    
	
 
    
	
 
    
	
/s/   Derik Mooberry
    	
 
    
	
Derik   Mooberry
    	
 
    

 

7

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00197-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00197-of-00352.parquet"}]]